Correlation Engine 2.0
Clear Search sequence regions


  • apoptosis (1)
  • cancers (2)
  • cck 8 (1)
  • cell growth (1)
  • cellular processes (1)
  • edu (1)
  • JNK (4)
  • leukemia (11)
  • lymphocytes (1)
  • microrna (1)
  • RBBP6 (5)
  • regulates (1)
  • regulates apoptosis (1)
  • rnas (4)
  • western blot (1)
  • Sizes of these terms reflect their relevance to your search.

    Acute lymphocytic leukemia (ALL) is a hematologic malignancy caused by the clonal proliferation of immature lymphocytes. Long noncoding RNAs (lncRNAs) have been reported as critical regulators in several cancers, including ALL. LncRNA SLCO4A1 antisense RNA 1 (SLCO4A1-AS1) has been revealed to be implicated in tumorigenesis of several cancers. Our study focused on the role of SLCO4A1-AS1 in ALL. RT-qPCR, Western blot analysis, CCK-8, EdU, and Flow cytometry analysis were used to explore the biological function of SLCO4A1-AS1 in ALL cellular processes. Luciferase reporter and RNA pull-down assays were applied to explore the mechanism of SLCO4A1-AS1 in ALL cells. SLCO4A1-AS1 was upregulated in ALL tissues and cell lines. We found that suppression of SLCO4A1-AS1 suppressed ALL cell proliferation and facilitated cell apoptosis. Our result confirmed that SLCO4A1-AS1 acted as a ceRNA by sponging microRNA 876-3p (miR-876-3p) to upregulate retinoblastoma binding protein 6 (RBBP6) expression in ALL cells. Moreover, SLCO4A1-AS1 activated the JNK signaling pathway by upregulating RBBP6. Rescue assays revealed that the activation of the JNK signaling or overexpression of RBBP6 revered the suppressive effect of SLCO4A1-AS1 knockdown on growth of ALL cells. SLCO4A1-AS1 promoted cell growth of ALL by the miR-876-3p/RBBP6 axis to activate the JNK signaling pathway. © 2021 John Wiley & Sons Ltd.

    Citation

    Jianping Mao, Wenliang Gao, Lianguo Xue, Juan Wang, Lidong Zhao. The lncRNA SLCO4A1-AS1/miR-876-3p/RBBP6 axis regulates cell proliferation and apoptosis in acute lymphocytic leukemia via the JNK signaling pathway. International journal of laboratory hematology. 2021 Oct;43(5):1050-1061


    PMID: 33683013

    View Full Text